Comprehensive ophthalmology-focused program supports providers, patients, and payors through coordinated specialty medication management
WHITTIER, Calif., Oct. 28, 2026 /PRNewswire-PRWeb/ -- Acelpa Health, a national network of specialty pharmacy and infusion services providers, today announced the launch of RetinaCare Complete, a comprehensive ophthalmology-focused program designed to help retina specialists and ophthalmology practices navigate the growing complexity of specialty medication management while supporting reliable patient access to sight-saving therapies.
As specialty medications play an increasingly important role in the treatment of retinal diseases and other ophthalmic conditions, providers face growing challenges related to medication access, reimbursement requirements, supply consistency, and treatment continuity. RetinaCare Complete was developed to help address these challenges through a coordinated model that supports providers, patients, and risk-bearing organizations throughout the specialty medication journey. In a recent survey conducted by Acelpa Health, nearly 90% of ophthalmology healthcare professionals indicated interest in transitioning to a specialty infusion partner model.
"RetinaCare Complete was developed in response to the growing complexity surrounding specialty medication management in ophthalmology," says George W. Kridner IV, CEO of Acelpa Health. "We saw an opportunity to help retina specialists and ophthalmology practices navigate these challenges through an integrated approach that supports reliable medication access and continuity of care."
RetinaCare Complete combines access to a broad portfolio of ophthalmic specialty therapies with support for specialty medication coordination, benefits investigation, prior authorization navigation, patient support services, and collaboration among providers, pharmacy teams, health plans, and patients to help ensure therapies are delivered when and where they are needed.
For retina specialists and ophthalmology practices, RetinaCare Complete is designed to support reliable access to specialty medications, consistent ordering and delivery processes, integrated support across pharmacy and health plan partners, and predictable supply for high-volume injection schedules. By helping streamline specialty medication management, the program enables providers to maintain their focus on delivering high-quality patient care.
In addition to supporting providers and patients, RetinaCare Complete helps risk-bearing organizations better manage high-volume ophthalmic specialty drug utilization through benefit alignment, streamlined workflows, utilization visibility, and support for consistent patient access to therapy. The program is designed to help align providers, pharmacies, and health plans around a shared approach to ophthalmic specialty medication management.
"Retina specialists and ophthalmology practices need a reliable partner that can help coordinate the many moving pieces involved in ophthalmic specialty therapies," says Ryan Skrable, Chief Business Development Officer, California Specialty Pharmacy, an Acelpa Health Company. "RetinaCare Complete was built to support consistent medication access, coordinated communication, and a more effective experience for providers and patients alike."
To learn more about RetinaCare Complete, visit https://acelpahealth.com/ophthalmology-2026/.
About Acelpa Health
Acelpa Health is a national platform that unites trusted specialty infusion providers – including California Specialty Pharmacy, ContinuumRx, Integrated Care Systems, Hawaii Specialty Pharmacy, and Continuum Health – under one umbrella, creating an integrated care model that combines national reach with local expertise and community-based support. Acelpa Health is dedicated to delivering high-quality specialty infusion pharmacy services – both at its ambulatory infusion centers and through home infusion – for patients living with complex, chronic, acute, and rare conditions. Through value-based partnerships and clinically driven programs, Acelpa Health provides personalized, high-touch support that enhances outcomes, reduces the cost of care, and expands access to critical therapies. With services spanning 39 states, the District of Columbia, Guam, and the U.S. Virgin Islands, the network includes nine licensed pharmacies and 21 infusion centers and provides access to more than 100 limited distribution drugs (LDDs). Our mission is to enhance patient health and quality of life through compassionate, comprehensive specialty infusion and pharmacy services – and to empower life beyond a diagnosis. For more information, visit: www.acelpahealth.com.
Media Contact
Jennifer Ringler, Acelpa Health, 1 973-647-5004, [email protected], https://acelpahealth.com/
SOURCE Acelpa Health
Share this article